Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The NIH announcement banner about its terminology transition was removed; the page’s error message and navigation remain unchanged.
    Difference
    1%
    Check dated 2026-11-10T16:41:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:53:04.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.” The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:06:10.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T18:16:34.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an error notice. This indicates restricted access to the trial information that users expect on this page.
    Difference
    17%
    Check dated 2026-09-22T22:24:33.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a backend or documentation update behind the page while the study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-15T20:22:18.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.